Castle Biosciences: Pay

Castle Biosciences paid its 4 named executives $13.9M in total in FY2025 (Dec). CEO Derek J. Maetzold was paid $6.8M of that.

Pay$100 in the stock at the end of FY20 → $58
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Derek J. MaetzoldPresident and CEO
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Frank StokesChief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Kristen M. OelschlagerChief Operating Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Tobin W. JuvenalChief Commercial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years

CEO pay against the pay peers

In FY2024 (Dec), the median CEO pay of the 8 peers with pay on file was $8.6M. The CEO of Castle Biosciences was paid $6.9M, 19% below the median.

  1. 1Natera
  2. 2Neogenomics
  3. 3CareDx
  4. 4Pacific Biosciences Of California
  5. 5Adma Biologics
  6. 6Twist Bioscience
  7. 7Castle Biosciences
  8. 8Veracyte
  9. 9Adaptive Biotechnologies
  10. 10Axonics, Inc.Not disclosed
  11. 11Biocryst PharmaceuticalsNot disclosed
  12. 12Guardant HealthNot disclosed
  13. 13Invitae CorporationNot disclosed
  14. 14Mesa Laboratories Inc /Co/Not disclosed
  15. 15OraSure Technologies, Inc.Not disclosed
  16. 16Quanterix CorporationNot disclosed
  17. 17Silk Road Medical, Inc.Not disclosed
  18. 18iRhythm Technologies, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.